December 21, 2016

Systemic inflammatory conditions combined affect more than 2 million Americans.

December 21, 2016

Walgreens has expanded the availability of prescription-free naloxone to 33 states and the District of Columbia.

December 16, 2016

Removal based on the outcomes of EAGLES, the largest smoking cessation clinical trial in patients without and with a history of psychiatric disorder.

December 15, 2016

The drug’s availability comes a year after the Food and Drug Administration approved it as a follow-on biologic to Lantus, another U-100 long-acting insulin. It has an amino acid sequence identical to that of Lantus. 

December 15, 2016

Expanding by 13 the list of vaccinations that can be administered to patients is part of the province's new strategy, Immunization 2020, which focuses on improving access to immunizations.

December 15, 2016

Walgreens ranks the top markets and states for flu activity in the U.S. It's the third year for Walgreens' Flu Index, and this year will include Puerto Rico for the first time.

December 14, 2016

Pfizer's Eucrisa came into its portfolio in May with the company’s acquisition of Anacor Pharmaceuticals, and Pfizer projects that it could bring in $2 billion or more in annual sales. 

December 13, 2016

The drug is indicated to improve blood sugar in adults with Type 2 diabetes when both empagliflozin and metformin can be taken.

December 13, 2016

Eli Lilly & Co. has outlined a new initiative, set to begin Jan. 1, 2017, that will offer access to Lilly insulin at discounted prices to patients via Blink Health’s mobile and web platforms through a partnership with Express Scripts. 

December 9, 2016
The focus of the initiative, which will see Lilly making an upfront payment of $30 million to AstraZeneca, is an antibody called MEDI1814, which can potentially slow the progression of the illness and is currently in Phase 1 trials. 
December 9, 2016

London Drugs is hoping to beat Shoppers Drug Mart to market in terms of dispensing medical marijuana, Canada's Tri-City News reported Thursday. “We’ll be as fast as the laws allow," London Drugs VP John Tse told the Candadian daily, "but it could happen overnight, we’re that ready." London Drug pharmacists are already reviewing potential drug-drug interactions. "We're interested from the perspective of how does it affect other medication the patient might be on and other health conditions they might have,” Tse said. “As a pharmacy we want it all documented properly so that we can advise patients and other health care professionals.” (Tri-City News)

December 8, 2016

In addition to returning the rights to Belbuca to BioDelivery Sciences International, Endo will be eliminating its 375-member pain sales field force in an effort to refocus its U.S. branded strategy on specialty, including its Xiaflex. 

December 8, 2016

The company told USA Today the cuts would take effect Feb. 10, with its Fairfax, Delaware headquarters seeing about 120 of the expected cuts, with other impacted roles spanning those that are field-based in both sales and non-sales. 

December 7, 2016

President Obama said in his Dec. 3 weekly address that he would sign the legislation into law "as soon as it reaches my desk."

December 7, 2016

In an interview with Time published Tuesday morning to accompany his being chosen as the magazine’s “Person of the Year,” President-elect Donald Trump told the magazine that one of his goals as president is lowering the cost of prescription drugs.  

December 6, 2016

The “Outlook for Global Medicines Through 2021: Balancing Cost and Value” report projects that total global spending will be close to $1.5 trillion on an invoice price basis through 2021.

December 2, 2016

The drug was approved by the Food and Drug Administration to treat multiple myeloma in patients who have received at least one other treatment.

November 30, 2016

The Rxight test provides information on medications covering 14 therapeutic classes, including pain, blood pressure, blood thinner, ADHD, anxiety, depression, diabetes, cancer, respiratory issues and other medications.

November 28, 2016

Impax announced Monday that it had appointed J. Kevin Buchi, CEO of TetraLogic Pharmaceuticals, to its board of directors. 

November 28, 2016

Both companies have confirmed that they are in preliminary discussions. 

November 22, 2016

Xultophy was approved the same day as Sanofi’s Soliqua 100/33, and the two are among the first in a new class of drugs that combine a GLP-1 agonist and long-lasting insulin.

November 22, 2016

Soliqua 100/33 combines Lantus and lixisenatide, a GLP-1 receptor agonist, in a once-daily injection.

November 21, 2016

Diplomat has begun dispensing Shire’s recently launched primary immunodeficiency treatment. 

November 18, 2016

According to the US Center for Disease Control and Prevention, immunizing pharmacists now administer roughly 25% of all influenza vaccinations.